Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Mallinckrodt
Express Scripts
AstraZeneca
Dow

Last Updated: January 22, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PEXIDARTINIB HYDROCHLORIDE

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

All Clinical Trials for Pexidartinib Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01525602 Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors Recruiting Plexxikon Phase 1 2012-05-01 The goal of this clinical study is to learn how PLX3397 and paclitaxel work together to affect the growth of cancer cells in advanced solid tumors.
NCT02734433 Study of Pexidartinib in Asian Subjects With Advanced Solid Tumors Recruiting Quintiles, Inc. Phase 1 2016-06-01 This is a Phase 1, non-randomized, open-label, multiple dose study of pexidartinib in Asian subjects with advanced solid tumors. The study will be conducted in a dose escalation to assess the safety and tolerability, PK and PD, and preliminary antitumor activity of pexidartinib.
NCT02734433 Study of Pexidartinib in Asian Subjects With Advanced Solid Tumors Recruiting Daiichi Sankyo Co., Ltd. Phase 1 2016-06-01 This is a Phase 1, non-randomized, open-label, multiple dose study of pexidartinib in Asian subjects with advanced solid tumors. The study will be conducted in a dose escalation to assess the safety and tolerability, PK and PD, and preliminary antitumor activity of pexidartinib.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Pexidartinib Hydrochloride

Condition Name

Condition Name for Pexidartinib Hydrochloride
Intervention Trials
Metastatic Cancer 1
Healthy Volunteers 1
Solid Tumors 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Pexidartinib Hydrochloride
Intervention Trials
Neoplasm Metastasis 1
Colorectal Neoplasms 1
Liver Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Pexidartinib Hydrochloride

Trials by Country

Trials by Country for Pexidartinib Hydrochloride
Location Trials
United States 17
Korea, Republic of 3
China 2
Taiwan 2
New Zealand 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Pexidartinib Hydrochloride
Location Trials
California 2
New York 2
Texas 2
Utah 1
Pennsylvania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Pexidartinib Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Pexidartinib Hydrochloride
Clinical Trial Phase Trials
Phase 1/Phase 2 1
Phase 1 7
Early Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Pexidartinib Hydrochloride
Clinical Trial Phase Trials
Recruiting 5
Not yet recruiting 3
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Pexidartinib Hydrochloride

Sponsor Name

Sponsor Name for Pexidartinib Hydrochloride
Sponsor Trials
Plexxikon 4
Daiichi Sankyo, Inc. 3
Quintiles, Inc. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Pexidartinib Hydrochloride
Sponsor Trials
Industry 12
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Merck
Colorcon
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.